CONCORD DRUGS LIMITED, established in 1995 as a public limited company, holds a prominent position among India's esteemed pharmaceutical companies. Specializing in the manufacturing of Finished Pharmaceutical Formulations such as Injectable (including Small Volume Parenterals and Dry Powder), Tissue Bio-Adhesive, tablets, capsules, ophthalmic preparations, and Ready-to-fill Pellets, the company boasts state-of-the-art technology. Its dedicated manufacturing facilities for Liquid Injections, Dry powder Injections, and Ready-to-fill Pellets ensure the utmost process integrity and product quality.
Initially focusing on Finished Pharmaceutical Formulations, the company later diversified into Ready-to-fill Pellets, offering customers comprehensive solutions for their diverse pharmaceutical product requirements through commercial contract drug manufacturing. Operating a cutting-edge, cGMP contract manufacturing Formulation-Fill-Finish facility, the company provides extensive pharmaceutical development and manufacturing services for drug products.
With two manufacturing facilities adhering to standards stipulated by Regulatory bodies, Concord Drugs Limited maintains its commitment to excellence in pharmaceutical manufacturing.
Initially focusing on Finished Pharmaceutical Formulations, the company later diversified into Ready-to-fill Pellets, offering customers comprehensive solutions for their diverse pharmaceutical product requirements through commercial contract drug manufacturing. Operating a cutting-edge, cGMP contract manufacturing Formulation-Fill-Finish facility, the company provides extensive pharmaceutical development and manufacturing services for drug products.
With two manufacturing facilities adhering to standards stipulated by Regulatory bodies, Concord Drugs Limited maintains its commitment to excellence in pharmaceutical manufacturing.
